Article Details

Venetoclax added to standard treatments shows promise in high-risk myeloid blood cancers

Retrieved on: 2020-12-05 20:15:00

Tags for this article:

Click the tags to see associated articles and topics

Venetoclax added to standard treatments shows promise in high-risk myeloid blood cancers. View article details on hiswai:

Excerpt

Reduced intensity conditioning chemotherapy is given to deplete the <b>immune</b> <b>system</b> of the patient (recipient) to prevent rejection of the donor stem ...

Article found on: www.eurekalert.org

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo